SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00073



SampleIDNumReplicatesOrganismTissueTypeCellTypeMHCAllele
SampleID
NumReplicates
Organism
TissueType
CellType
MHCAllele
SYSMHC00073_MDA_MB231_Rep1_IFN_positive 9 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
SYSMHC00073_MDA_MB231_Rep1_IFN_positive_classII 10 Human DRB1_0701,DRB1_1305,HLA-DPA10201-DPB11701,HLA-DQA10202-DQB10301
SYSMHC00073_MDA_MB231_Rep2_IFN_negative 9 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
SYSMHC00073_MDA_MB231_Rep3_IFN_positive_classII 10 Human DRB1_0701,DRB1_1305,HLA-DPA10201-DPB11701,HLA-DQA10202-DQB10301
SYSMHC00073_MDAMB231_IFN_positive_rep5_Immuno_classI 9 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
SYSMHC00073_MDAMB231_IFN_positive_rep5_Immuno_classII 10 Human DRB1_0701,DRB1_1305,HLA-DPA10201-DPB11701,HLA-DQA10202-DQB10301
SYSMHC00073_TNBC_IFN_negative_rep1 6 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
SYSMHC00073_TNBC_IFN_negative_rep2 6 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
SYSMHC00073_TNBC_IFN_negative_rep3 6 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
SYSMHC00073_TNBC_IFN_negative_rep4 9 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
SYSMHC00073_TNBC_IFN_negative_rep5 9 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
SYSMHC00073_TNBC_IFN_positive_rep4 9 Human HLA-A02_01,HLA-A01_17,HLA-B40_02,HLA-B41_01,HLA-C02_02,HLA-C17_01
Showing 1 to 11 of 12 entries



Detailed view of sample SYSMHC00073_TNBC_IFN_negative_rep4



IDSampleIDRawFileNameProcessCulture ConditionsDisease StateCommentsMHCClassPubMed IDPeptideIsolation MethodAntibodyMass SpectrometerLC SystemiRT PeptidesAcquisition ModeFragmentation MethodGradientGradient LengthFlow RateReplicate Number
ID
SampleID
RawFileName
Organism
Process
Tissue Type
Cell Type
Culture Conditions
Disease State
Comments
MHCClass
MHCAllele
PubMed ID
Peptide
Isolation Method
Antibody
Mass Spectrometer
LC System
iRT Peptides
Acquisition Mode
Fragmentation Method
Gradient
Gradient Length
Flow Rate
Replicate Number
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool1.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 1
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool2.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 2
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool3.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 3
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool4.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 4
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool5.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 5
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool6.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 6
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool7.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 7
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool8.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 8
SYSMHC00073 SYSMHC00073_TNBC_IFN_negative_rep4 F120190823_PF_TNBC_IFN_negative_Rep4_pool9.raw In vitro adherent Breast carcinoma class I PXD023038 native Immunoaffinity W6/32 Orbitrap Fusion Lumos no DDA HCD 0-80% ACN 65 250 nl/min 9
Showing 1 to 2 of 9 entries